Answers are grounded in this paper and cite their sources.
Underreporting issues require immediate attention among healthcare professionals due to a lack of awareness and knowledge of pharmacovigilance and adverse drug reaction reporting. Educational and training program interventions have been suggested by most studies to address these issues.
No takes yet. Share an insight, caveat, or question.
Putri et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: